Tech Company Financing Transactions
iSpecimen Funding Round
iSpecimen secured a $8 million Series B funding round on 9/5/2014. Investors included OneBlood.
Transaction Overview
Company Name
Announced On
9/5/2014
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors
OneBlood (Bud Scholl)
Proceeds Purpose
New investor OneBlood will help grow iSpecimen's healthcare partner network and scale operations to meet the ever increasing needs of its research customers for annotated human biospecimens.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
450 Bedford St.
Lexington, MA 02420
USA
Lexington, MA 02420
USA
Phone
Website
Email Address
Overview
iSpecimen is a supplier of human clinical specimens to the therapeutic, diagnostic and academic research industries. Our mission is to make it easy for medical researchers to access liquid and solid clinical lab specimens.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Ianelli
Chief Medical Officer
David Wages
Chief Operating Officer
Jill Mullan
VP - Bus. Development
Eric Langlois
VP - Operations
Dawn Michelle
Browse more venture capital transactions:
Prev: 9/5/2014: Syntellia venture capital transaction
Next: 9/5/2014: Sonendo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs